- Home
- ACHR vs XENE Comparison
ACHR vs XENE Comparison
Compare ACHR & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACHR | XENE |
|---|---|---|
| Founded | 2018 | 1996 |
| Country | United States | Canada |
| Employees | 1660 | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 5.2B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | ACHR | XENE |
|---|---|---|
| Price | $5.09 | $52.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 11 |
| Target Price | $12.00 | ★ $68.55 |
| AVG Volume (30 Days) | ★ 51.6M | 1.3M |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $311,000.00 |
| Revenue This Year | $4,986.67 | N/A |
| Revenue Next Year | $876.87 | $2,496.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.80 | $30.00 |
| 52 Week High | $14.62 | $62.91 |
Technical Indicators
Market Signals| Indicator | ACHR | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 35.50 | 42.63 |
| Support Level | $4.80 | $39.93 |
| Resistance Level | $7.40 | $59.43 |
| Average True Range (ATR) | 0.44 | 1.68 |
| MACD | -0.17 | -0.11 |
| Stochastic Oscillator | 7.64 | 26.46 |
Price Performance
Historical ComparisonAbout ACHR Archer Aviation Inc.
Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner. The company is building a platform to deliver aircraft, technologies, and services to customers world-wide across commercial and defense sectors.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.